⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23559914 | 1.00 | — | — | |
| SCHEMBL22525606 | 0.76 | — | — | |
| SCHEMBL23572289 | 0.76 | — | — | |
| SCHEMBL29331615 | 0.74 | LIPE (0.33) | — | |
| SCHEMBL25118225 | 0.72 | JAK2 (0.31) | — | |
| SCHEMBL24673660 | 0.72 | JAK2 (0.31) | — | |
| SCHEMBL25006291 | 0.71 | — | — | |
| SCHEMBL23945120 | 0.71 | — | — | |
| SCHEMBL25471720 | 0.67 | — | — | |
| SCHEMBL29331606 | 0.64 | LIPE (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022087216-A1 | DOUBLE DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2022-04-28 | — | — | WO | disclosed |